Logo image of MRBK

MERIDIAN CORP (MRBK) Stock Fundamental Analysis

NASDAQ:MRBK - Nasdaq - US58958P1049 - Common Stock - Currency: USD

13.89  -0.24 (-1.7%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to MRBK. MRBK was compared to 397 industry peers in the Banks industry. MRBK has a bad profitability rating. Also its financial health evaluation is rather negative. MRBK is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

MRBK had positive earnings in the past year.
MRBK had a positive operating cash flow in the past year.
MRBK had positive earnings in each of the past 5 years.
Of the past 5 years MRBK 4 years had a positive operating cash flow.
MRBK Yearly Net Income VS EBIT VS OCF VS FCFMRBK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

MRBK has a worse Return On Assets (0.64%) than 66.25% of its industry peers.
The Return On Equity of MRBK (9.26%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA 0.64%
ROE 9.26%
ROIC N/A
ROA(3y)0.78%
ROA(5y)1.19%
ROE(3y)10.71%
ROE(5y)14.46%
ROIC(3y)N/A
ROIC(5y)N/A
MRBK Yearly ROA, ROE, ROICMRBK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 13.99%, MRBK is doing worse than 78.84% of the companies in the same industry.
MRBK's Profit Margin has been stable in the last couple of years.
The Operating Margin and Gross Margin are not available for MRBK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 13.99%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-14.84%
PM growth 5Y-0.78%
GM growth 3YN/A
GM growth 5YN/A
MRBK Yearly Profit, Operating, Gross MarginsMRBK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

More info and screens

1

2. Health

2.1 Basic Checks

MRBK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MRBK has been increased compared to 1 year ago.
The number of shares outstanding for MRBK has been reduced compared to 5 years ago.
MRBK has a better debt/assets ratio than last year.
MRBK Yearly Shares OutstandingMRBK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
MRBK Yearly Total Debt VS Total AssetsMRBK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

MRBK has a debt to FCF ratio of 6.21. This is a slightly negative value and a sign of low solvency as MRBK would need 6.21 years to pay back of all of its debts.
MRBK has a worse Debt to FCF ratio (6.21) than 73.30% of its industry peers.
MRBK has a Debt/Equity ratio of 1.09. This is a high value indicating a heavy dependency on external financing.
MRBK's Debt to Equity ratio of 1.09 is on the low side compared to the rest of the industry. MRBK is outperformed by 86.40% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.09
Debt/FCF 6.21
Altman-Z N/A
ROIC/WACCN/A
WACC23.98%
MRBK Yearly LT Debt VS Equity VS FCFMRBK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
MRBK Yearly Current Assets VS Current LiabilitesMRBK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 9.52% over the past year.
Measured over the past years, MRBK shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.10% on average per year.
Looking at the last year, MRBK shows a quite strong growth in Revenue. The Revenue has grown by 13.50% in the last year.
MRBK shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.11% yearly.
EPS 1Y (TTM)9.52%
EPS 3Y-38.52%
EPS 5Y-6.1%
EPS Q2Q%-16.67%
Revenue 1Y (TTM)13.5%
Revenue growth 3Y-9.41%
Revenue growth 5Y10.11%
Sales Q2Q%10.19%

3.2 Future

Based on estimates for the next years, MRBK will show a very strong growth in Earnings Per Share. The EPS will grow by 34.80% on average per year.
Based on estimates for the next years, MRBK will show a quite strong growth in Revenue. The Revenue will grow by 11.04% on average per year.
EPS Next Y30.71%
EPS Next 2Y34.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.51%
Revenue Next 2Y11.04%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
MRBK Yearly Revenue VS EstimatesMRBK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
MRBK Yearly EPS VS EstimatesMRBK Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4 5

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

MRBK is valuated correctly with a Price/Earnings ratio of 12.08.
The rest of the industry has a similar Price/Earnings ratio as MRBK.
MRBK is valuated cheaply when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 6.42 indicates a rather cheap valuation of MRBK.
MRBK's Price/Forward Earnings ratio is rather cheap when compared to the industry. MRBK is cheaper than 92.44% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.76, MRBK is valued rather cheaply.
Industry RankSector Rank
PE 12.08
Fwd PE 6.42
MRBK Price Earnings VS Forward Price EarningsMRBK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of MRBK indicates a rather cheap valuation: MRBK is cheaper than 90.68% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 5.14
EV/EBITDA N/A
MRBK Per share dataMRBK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

MRBK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MRBK's earnings are expected to grow with 34.80% in the coming years.
PEG (NY)0.39
PEG (5Y)N/A
EPS Next 2Y34.8%
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

MRBK has a Yearly Dividend Yield of 3.54%.
MRBK's Dividend Yield is a higher than the industry average which is at 3.31.
Compared to an average S&P500 Dividend Yield of 2.35, MRBK pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.54%

5.2 History

MRBK has been paying a dividend for over 5 years, so it has already some track record.
The dividend of MRBK decreased recently.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
MRBK Yearly Dividends per shareMRBK Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

34.91% of the earnings are spent on dividend by MRBK. This is a low number and sustainable payout ratio.
DP34.91%
EPS Next 2Y34.8%
EPS Next 3YN/A
MRBK Yearly Income VS Free CF VS DividendMRBK Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M
MRBK Dividend Payout.MRBK Dividend Payout, showing the Payout Ratio.MRBK Dividend Payout.PayoutRetained Earnings

More info and screens

MERIDIAN CORP

NASDAQ:MRBK (7/11/2025, 8:00:00 PM)

13.89

-0.24 (-1.7%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)04-25 2025-04-25/dmh
Earnings (Next)07-25 2025-07-25
Inst Owners61.24%
Inst Owner Change0%
Ins Owners9.87%
Ins Owner Change0.98%
Market Cap156.82M
Analysts80
Price Target17.34 (24.84%)
Short Float %0.37%
Short Ratio0.49
Dividend
Industry RankSector Rank
Dividend Yield 3.54%
Yearly Dividend0.5
Dividend Growth(5Y)N/A
DP34.91%
Div Incr Years0
Div Non Decr Years1
Ex-Date05-12 2025-05-12 (0.125)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-36.18%
Min EPS beat(2)-39.67%
Max EPS beat(2)-32.69%
EPS beat(4)1
Avg EPS beat(4)-15.11%
Min EPS beat(4)-39.67%
Max EPS beat(4)17.65%
EPS beat(8)2
Avg EPS beat(8)-18.75%
EPS beat(12)4
Avg EPS beat(12)-13.15%
EPS beat(16)8
Avg EPS beat(16)-4.76%
Revenue beat(2)1
Avg Revenue beat(2)-0.49%
Min Revenue beat(2)-4.86%
Max Revenue beat(2)3.87%
Revenue beat(4)2
Avg Revenue beat(4)1.51%
Min Revenue beat(4)-4.86%
Max Revenue beat(4)7.39%
Revenue beat(8)4
Avg Revenue beat(8)-0.44%
Revenue beat(12)4
Avg Revenue beat(12)-2.77%
Revenue beat(16)7
Avg Revenue beat(16)-1.49%
PT rev (1m)0%
PT rev (3m)-5.56%
EPS NQ rev (1m)2.44%
EPS NQ rev (3m)3.7%
EPS NY rev (1m)0%
EPS NY rev (3m)-11.34%
Revenue NQ rev (1m)0.46%
Revenue NQ rev (3m)-0.7%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.44%
Valuation
Industry RankSector Rank
PE 12.08
Fwd PE 6.42
P/S 1.37
P/FCF 5.14
P/OCF 5.33
P/B 0.9
P/tB 0.95
EV/EBITDA N/A
EPS(TTM)1.15
EY8.28%
EPS(NY)2.16
Fwd EY15.57%
FCF(TTM)2.7
FCFY19.45%
OCF(TTM)2.61
OCFY18.76%
SpS10.17
BVpS15.37
TBVpS14.67
PEG (NY)0.39
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.64%
ROE 9.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 13.99%
GM N/A
FCFM 26.56%
ROA(3y)0.78%
ROA(5y)1.19%
ROE(3y)10.71%
ROE(5y)14.46%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-14.84%
PM growth 5Y-0.78%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 1.09
Debt/FCF 6.21
Debt/EBITDA N/A
Cap/Depr 291.13%
Cap/Sales 0.94%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 189.83%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score7
WACC23.98%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)1.64%
Cap/Sales(5y)1.8%
Profit Quality(3y)186.36%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.52%
EPS 3Y-38.52%
EPS 5Y-6.1%
EPS Q2Q%-16.67%
EPS Next Y30.71%
EPS Next 2Y34.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)13.5%
Revenue growth 3Y-9.41%
Revenue growth 5Y10.11%
Sales Q2Q%10.19%
Revenue Next Year11.51%
Revenue Next 2Y11.04%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-52.11%
FCF growth 3Y-61.62%
FCF growth 5Y-15.45%
OCF growth 1Y-55.96%
OCF growth 3Y-61.26%
OCF growth 5Y-14.98%